Navigation Links
2 new therapies show promise for cancer patients
Date:4/15/2008

San Diego and PhoenixApril 15, 2008Clinical researchers at Scottsdale Healthcare and TGen today announced the results of two clinical trials that show promise for patients battling cancer.

The Phase I clinical trial findings, presented at the this weeks Annual Meeting of the American Association for Cancer Research by Daniel Von Hoff, MD, FACG, focused on basal cell carcinoma (BCC) and pancreatic cancer. The Arizona trials were conducted at TGen's Clinical Research Service (TCRS) at Scottsdale Healthcare, a strategic alliance between TGen and Scottsdale Healthcares Clinical Research Institute.

Basal Cell Carcinoma

In the first trial, a novel molecule, GDC-0449, shrinks tumors in basal cell carcinoma (BCC) while having limited side effects, including a loss of sense of taste, and a small amount of hair loss and weight loss, suggesting a viable new treatment option. GDC-0449 works by blocking a pathway a series of chemical reactions within a cell known as Hedgehog, containing two genes (PTCH and SMO) that lead to a known tumor-promoting gene called GLI1. Alterations in any of these genes have been shown to lead to basal cell carcinoma and other diseases. GDC-0449 is a chemical synthetic designed to replicate the properties of cyclopamine, a chemical found in nature.

Basal cell carcinoma affects about one million people a year and a proportion of these patients have disease that is not curable with surgery. We currently do not have any treatments that can effectively slow tumor growth in these advanced patients. This finding has potential importance in this population, said Daniel D. Von Hoff, M.D., Physician in Chief at the Translational Genomics Research Institute (TGen) and Chief Medical Officer for the Scottsdale Clinical Research Institute at Scottsdale Healthcare.

Typically diagnosed with a simple biopsy, the risk of BCC increases for those individuals with a family history, or prolonged exposure to ultr
'/>"/>

Contact: Galen Perry
gperry@tgen.org
602-343-8423
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Linchpin gene may be useful target for new breast cancer therapies
2. NCI renewal grant to develop new cancer therapies
3. The construction of heart modelling leads path to new therapies
4. Challenges and promise of cell-based therapies
5. Innovative civil engineering application promises cleaner waters
6. New CPR promises better results by compressing abdomen, not Chest
7. Tiny tubes and rods show promise as catalysts, sunscreen
8. New genetic research into nicotine addiction shows promise for personalized treatment
9. Genetic ancestral testing cannot deliver on its promise, study warns
10. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
11. Summer-dormant tall fescue grass shows promise for pasture improvements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2015)... August 11, 2015 Today, ZUK announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
(Date:8/5/2015)... Calif. , Aug. 5, 2015 The ... continuous growth in applications, penetration into newer sectors, and ... year. The global biosensors space has seen the entry ... the market so far. (Photo - ... & Sullivan, Analysis of the Global Biosensors Market ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... culprits in expanding waistlines and killer diseases, but scientific understanding ... inside cells in the body got short shrift until launch ... the cover story in the current edition of Chemical ... article focuses on a massive effort, little-known outside the ...
... have developed a computer programme that enables regulators to ... conservation, whale watching and marine transportation activities in the ... the collision risk with whales while taking into account ... Parrott, who headed the research team. The model, developed ...
... consider a "dinosaur" may be the best solution for ... of Illinois associate professor of weed physiology. "Farmers ... herbicides," Riechers said. "But herbicide resistance is bad enough ... illustrates how severe this problem is." In a ...
Cached Biology News:New computer program promises to save the whales 2New computer program promises to save the whales 3Which direction are herbicides heading? 2Which direction are herbicides heading? 3
(Date:9/3/2015)... 2015 According to a new ... (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, Detectors, Fraction ... - Analysis & Global Forecasts to 2020", published by ... around 9.223 Billion by 2020 from USD 7.062 Billion ... Browse 141 tables and 36 figures spread through 277 ...
(Date:9/3/2015)... ... September 03, 2015 , ... Michigan-based technology ... wearable early 2016. , The device, called the Halo H1, is a ... electrical sensing technology. These sensors track trending interstitial fluid levels in the body, ...
(Date:9/2/2015)... Axovant Sciences Ltd. (NYSE:  AXON), a leading clinical-stage ... upcoming presentations at three investor conferences: , Wednesday, ... Conference in New York at the ... 2:00 PM at the BioCentury NewsMakers Conference in ... Conference Center , Thursday, September 17 at 9:30 AM ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... regulatory compliance, quality systems, analytical testing, education and consulting services for the ... in medical device products/processes development, design control, validation, quality assurance and regulatory ...
Breaking Biology Technology:Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7
... components benefit from decreased size, antennaswhether in a ... gain, efficiency, system range, and bandwidth when their ... attention has been directed toward producing antennas by ... simple motifs, such as dipoles and loops," explained ...
... Regent is conducting a nationwide voluntary recall of the ... Dose VialsNDC # 0517-4901-25;andDexamethasone Sodium Phosphate Injection, 4 mg/mL, ... Injection, 4 mg/mL, 30 mL Multiple Dose VialsNDC # ... initiated on March 16, 2011 to the User Level, ...
... 2011 Reportlinker.com announces that a new market ... Global Growth Factors ( Blood ... http://www.reportlinker.com/p0397766/Global-Growth-Factors--Blood-And-Tissue--Industry.html This report analyzes ... Tissue) in US$ Million by the following growth ...
Cached Biology Technology:3-D printing method advances electrically small antenna design 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 3American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 4American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 5Global Growth Factors ( Blood And Tissue ) Industry 2Global Growth Factors ( Blood And Tissue ) Industry 3Global Growth Factors ( Blood And Tissue ) Industry 4Global Growth Factors ( Blood And Tissue ) Industry 5Global Growth Factors ( Blood And Tissue ) Industry 6Global Growth Factors ( Blood And Tissue ) Industry 7Global Growth Factors ( Blood And Tissue ) Industry 8Global Growth Factors ( Blood And Tissue ) Industry 9Global Growth Factors ( Blood And Tissue ) Industry 10Global Growth Factors ( Blood And Tissue ) Industry 11Global Growth Factors ( Blood And Tissue ) Industry 12Global Growth Factors ( Blood And Tissue ) Industry 13Global Growth Factors ( Blood And Tissue ) Industry 14Global Growth Factors ( Blood And Tissue ) Industry 15Global Growth Factors ( Blood And Tissue ) Industry 16
... Epitope: A BALB/c mouse ... Recommended Storage: Store vial at -20 ... freeze at -20 C or below for extended ... Centrifuge product if not completely clear after ...
... The National Instruments PCIe-1429 is the ... the NI PCIe-1429, you now can acquire ... bit depths available for Camera Link cameras ... synchronized data and image acquisition, fault analysis, ...
Amodiaquine...
... provides unique aptamer microarray services using ... databases, and sequence design software to ... and screening of aptamers as drug ... with sequence design, synthesis of standard ...
Biology Products: